June 06, 2025

RSV or COVID: Which Strains the Heart?

A study of 32,960 hospitalizations finds 10.9% of patients with RSV experienced acute cardiovascular events, with significantly higher adjusted odds than boosted and unboosted COVID-19 cases.

Conexiant

June 05, 2025

Risky College Behaviors Harming Oral Health?

First-year university students who adopted unhealthy habits such as poor diet, vaping, and reduced brushing frequency experienced significant declines in self-reported oral health over 6 months.

Conexiant

June 05, 2025

Can Adolescent Diets Predict Fatherhood?

New research shows fathers who improved their diet as teenagers were more likely to promote healthy eating in their children and had kids who ate more fruits and vegetables.

Conexiant

June 04, 2025

Restrictive Eating Tied to Depression in Men

A UK study found that dietary restraint is linked to higher depressive symptoms, with stronger effects seen in men and individuals with elevated BMI.

Conexiant

June 04, 2025

Oat Fiber Intake Tied to PFAS Reduction

A Canadian study found widespread PFAS exposure in adult men and observed that a four-week oat fiber intervention modestly reduced some long-chain PFAS levels in blood, with liver enzyme elevations linked to certain PFAS types.

Conexiant

June 03, 2025

Phytosterols May Shield Against Diabetes, CVD

Large Harvard study shows higher phytosterol intake, particularly beta-sitosterol, reduces type 2 diabetes and cardiovascular disease risk by up to 9%.

Conexiant

June 02, 2025

New COVID Vaccine Approved for High-Risk Groups

After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.

Conexiant

May 30, 2025

Major Medical Societies Issue GLP-1 Nutrition Guidelines

New advisory addresses nutritional challenges and side effects for obesity treatment

Conexiant

May 29, 2025

FDA Approves First Hydrocortisone Oral Solution

The FDA has approved Khindivi, the first hydrocortisone oral solution for pediatric adrenal insufficiency, offering precise, ready-to-use dosing for patients aged 5 years and older.

Conexiant